Javascript must be enabled to continue!
Shock Index and Modified Shock Index Are Predictors of Long-Term Mortality in STEMI and NSTEMI Patients
View through CrossRef
Background: Acute coronary syndromes (ACS), including STEMI and NSTEMI, are leading causes of mortality worldwide. The Shock Index (SI) and Modified Shock Index (MSI) are non-invasive markers traditionally used to assess hemodynamic status but their role in predicting long-term mortality in ACS patients is less understood.
Objective: To evaluate the prognostic value of SI and MSI in predicting long-term mortality among patients with STEMI and NSTEMI.
Methods: A prospective cohort study was conducted on 275 consecutive patients diagnosed with STEMI and NSTEMI at the Department of Cardiology, PIMS, Islamabad, between March 1, 2024, and July 31, 2024. Patients were divided into two groups: Group 1 (n=138) assessed using SI and Group 2 (n=137) using MSI. Follow-up for three years was conducted to record all-cause mortality. Data were analyzed using SPSS version 25.0, with Cox proportional hazards regression and Kaplan-Meier survival analysis employed to assess mortality risk.
Results: During the three-year follow-up, mortality rates were 24.6% in the SI group and 26.3% in the MSI group. Higher SI and MSI values were significantly associated with increased mortality (SI HR=1.85, 95% CI: 1.35-2.54, p<0.001; MSI HR=2.10, 95% CI: 1.50-2.93, p<0.001).
Conclusion: SI and MSI are significant predictors of long-term mortality in STEMI and NSTEMI patients and should be integrated into routine clinical assessments for better risk stratification.
Title: Shock Index and Modified Shock Index Are Predictors of Long-Term Mortality in STEMI and NSTEMI Patients
Description:
Background: Acute coronary syndromes (ACS), including STEMI and NSTEMI, are leading causes of mortality worldwide.
The Shock Index (SI) and Modified Shock Index (MSI) are non-invasive markers traditionally used to assess hemodynamic status but their role in predicting long-term mortality in ACS patients is less understood.
Objective: To evaluate the prognostic value of SI and MSI in predicting long-term mortality among patients with STEMI and NSTEMI.
Methods: A prospective cohort study was conducted on 275 consecutive patients diagnosed with STEMI and NSTEMI at the Department of Cardiology, PIMS, Islamabad, between March 1, 2024, and July 31, 2024.
Patients were divided into two groups: Group 1 (n=138) assessed using SI and Group 2 (n=137) using MSI.
Follow-up for three years was conducted to record all-cause mortality.
Data were analyzed using SPSS version 25.
0, with Cox proportional hazards regression and Kaplan-Meier survival analysis employed to assess mortality risk.
Results: During the three-year follow-up, mortality rates were 24.
6% in the SI group and 26.
3% in the MSI group.
Higher SI and MSI values were significantly associated with increased mortality (SI HR=1.
85, 95% CI: 1.
35-2.
54, p<0.
001; MSI HR=2.
10, 95% CI: 1.
50-2.
93, p<0.
001).
Conclusion: SI and MSI are significant predictors of long-term mortality in STEMI and NSTEMI patients and should be integrated into routine clinical assessments for better risk stratification.
Related Results
Clinico-functional particularities of deceased patients with STEMI and NSTEMI 12 months after revascularization
Clinico-functional particularities of deceased patients with STEMI and NSTEMI 12 months after revascularization
Introduction: Acute myocardial infarction remains a leading cause of cardiovascular mortality worldwide [1 ]. However, ST-elevation MI (STEMI) and non-ST-elevation MI (NSTEMI) pati...
Common predictors of death in patients with STEMI and NSTEMI during 1st year of postinfarction period
Common predictors of death in patients with STEMI and NSTEMI during 1st year of postinfarction period
Abstract
Aim
Evaluation the levels of markers having highest prediction value regarding the risk of death in patients wit...
Subfatin concentration decreases in acute coronary syndrome
Subfatin concentration decreases in acute coronary syndrome
We investigated the association of serum subfatin concentration and acute myocardial infarction (AMI) in patients with ST-elevation myocardial infarction (STEMI) and non-STEMI (NST...
Abstract 14211: Positive Predictive Value of Troponin for NSTEMI Based on Chief Complaint
Abstract 14211: Positive Predictive Value of Troponin for NSTEMI Based on Chief Complaint
Introduction:
Serum troponin is a ubiquitous biomarker used to diagnose acute myocardial infarction (AMI). The positive predictive value (PPV) of high-sensitivity tropo...
342 Impact of temporary traffic bans on the risk of acute coronary syndromes in a large metropolitan area
342 Impact of temporary traffic bans on the risk of acute coronary syndromes in a large metropolitan area
Abstract
Aims
Strong epidemiologic evidence has highlighted the role of pollution, on top of adverse climate features, as a nove...
What is the evidence for IABP in STEMI with and without cardiogenic shock?
What is the evidence for IABP in STEMI with and without cardiogenic shock?
Intraaortic balloon pump (IABP) is the most widely used left ventricular support device in a variety of indications. This review focuses on the current literature and discusses the...
Neutrophil Dynamics in Acute Coronary Syndrome
Neutrophil Dynamics in Acute Coronary Syndrome
Aims: Clinical evidence indicates that innate immune cells may contribute to the onset and outcome of acute coronary syndrome (ACS). Our prospective study aimed at analysing neutro...
Diagnosis and management of non-STEMI coronary syndromes
Diagnosis and management of non-STEMI coronary syndromes
Abstract
Acute coronary syndromes are classified as ST segment elevation myocardial infarction (STEMI), non-STEMI (NSTEMI) or unstable angina. Most patients with NST...

